The amount of effort Google seems to put into its Pixel phones while simultaneously ensuring that they look and feel mundane never ceases to astonish me. The new Pixel 5 is the epitome of this trend, though it’s been present since the beginning.
The Pixel 5 is unassuming. Instead of pushing the state of the art forward, Google has seemingly retreated to simpler, more reliable, and less expensive technology. The Pixel 4 had face unlock, squeezable sides, and a literal radar chip. The Pixel 5 has a simple rear-mounted fingerprint sensor that harkens back to Android phones from 2018, not 2020.
And yet, it’s still a very good phone for $699. It’s not impressive or flashy. By spending just a little (or a lot) more money, you can get better specs, larger camera arrays, prettier screens, and fancier designs. The Pixel 5 is trying to sell something else, sometimes to
Tumors come in many shapes and forms — curable or deadly, solid or liquid, lodged inside the brain, bone, or other tissues. One thing they all have in common, however, is a knack for molecular deceit. It is often by posing as normal cells, or by hijacking them, that cancer cells advance their takeover of biological systems and learn to grow, survive, and spread to new organs.
Recently, Rockefeller scientists found that breast and lung tumors can appropriate a signaling pathway used by neurons to metastasize. In a report published in Nature, the researchers describe how these cancer cells enlist nearby blood vessels to gain access to this nerve signal, ultimately enabling their escape from the primary tumor and into the bloodstream.
In addition to illuminating previously unseen aspects of tumors’ relationship with their surroundings, the findings could lead to new strategies for diagnostics and treatment.